Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venlafaxine versus vestibular rehabilitation for persistent postural-perceptual dizziness
IRCT20230803059017N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of venlafaxine in psychogenic dizziness (PPPD) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: dizziness. Started Aug 2023; status: completed.
02
Drugs
venlafaxine
03
Conditions
psychogenic dizziness (PPPD)
Beyond the preview
Go deeper on IRCT20230803059017N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230803059017N1.